Residual solvents and scavengers: what is looked for
Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be stated separately from the purity.
On post #4 — agreed on the reasoning, with one qualification.
Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species appear. Reducing conditions (like DTT) convert them back.
Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in the area percentage.
Picking up post #15: that is the part I would want checked first.
Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural isomer with the same mass but a different sequence. No chromatographic purity method detects this without a reference standard.
Read the full topic (24 posts)
This topic was referenced in
- Particulates in a reconstituted solution: identifying the likely source — what changed sinceAnalytics › Impurities & related substances · 2 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Impurity thresholds: where the common numbers come from
Impurity thresholds: where the common numbers come from — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
|
+11 | 15 | 825 | 2d |
|
A rising related-substance total over six months: degradation or method drift?
Asking directly, because I could not find a straight answer: A rising related-substance total over six months: degradation or method drift? Posting the method first, because I know what the first three…
|
+37 | 42 | 37k | 23mo |
|
Second pass at: Where impurities in solid-phase peptide synthesis come from
Posting this under the heading it deserves: Second pass at: Where impurities in solid-phase peptide synthesis come from Everything below is what sits behind that. A documentation question rather than an…
|
+47 | 51 | 3.3k | 5mo |
|
Coming back to: Oxidation pathways for methionine and tryptophan
Oxidation pathways for methionine and tryptophan Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+1 | 5 | 36k | 15mo |
|
Trifluoroacetate content and its consequences
Trifluoroacetate content and its consequences — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in front of me…
|
+123 | 134 | 31k | 5mo |
Related topics — sharing the tags counter-ion content, HPLC, data table
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Blinding yourself: practical methods and their limits
On the subject in the title: Blinding yourself: practical methods and their limits Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med , 2019) with STEP 4 ( JAMA , 2021) and finding the…
|
+40 | 44 | 33k | 5d |
|
Second pass at: Isotonicity and what happens when you get it wrong
Second pass at: Isotonicity and what happens when you get it wrong — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked.…
|
+1 | 5 | 2.6k | 11mo |
|
Why most self-reports here are not experiments, and that is fine
Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in…
|
2 | 46k | 11mo | |
|
Washout with a one-week half-life: the arithmetic
Washout with a one-week half-life: the arithmetic — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not think it…
|
+90 | 96 | 44k | 20mo |
|
Revisiting: Why I ask for the gradient before I discuss the number
Posting this under the heading it deserves: Revisiting: Why I ask for the gradient before I discuss the number Everything below is what sits behind that. I would like to understand what this number means…
|
+15 | 19 | 43k | 10mo |